I47.2
Conditions
Interventions
Group 1: Ablation of monomorphic ventricular tachycardia
Sponsors
Universitäres Herzzentrum Freiburg-Bad Krozingen
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Male and female patients aged =18 years undergoing VT ablation 2. Written informed consent for registry participation prior to enrollment 3. Ability to understand the nature of the registry and the registry related procedures and to comply with them
Exclusion criteria
Exclusion criteria: 1. Inability to comply with the registry procedures 2. Patient is unable or unwilling to provide informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of recurrent ventricular tachycardias or adequate ICD therapies | — |
Secondary
| Measure | Time frame |
|---|---|
| • Assessment of baseline characteristics • Assessment of underlying structural heart diseases • Evaluation of factors influencing short- and long-term ablation success • Assessment of periprocedural mapping parameter • Assessment of all-cause mortality • Assessment of influence of preprocedural imaging • Assessment of periprocedural complications • Assessment of applied treatments for VTs • Assessment of echocardiographic parameters • Identification of protein candidates/biomarkers for VT recurrences or hemodynamic detoriation during VT episodes • Assessment of recurrent ICD therapies | — |
Countries
Germany
Contacts
Public ContactJulian Müller
Universitäres Herzzentrum Freiburg-Bad Krozingen
Outcome results
None listed